SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is trending following news of Madryn Asset Management acquiring a significant 91% stake, prompting discussions about potential privatization or delisting to reduce costs. This has ignited debate among traders, with bulls anticipating a massive short squeeze due to the extremely low public float, while skeptics warn of a pump-and-dump scenario. The community is actively discussing the implications of this majority ownership on the stock's future, balancing hopes for a continued rally against concerns for potential dilution or a low buyout.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing significant momentum following Saudi FDA approval for its ANKTIVA drug in both lung and bladder cancer, alongside a reported 700% surge in full-year revenue. The community is buzzing with anticipation of a potential short squeeze and substantial long-term upside, while actively discussing the implications of this international recognition for future U.S. approvals. Many are calling for the US FDA to accelerate its review, highlighting the drug's broad applicability across various cancer types and potential for new financial partnerships.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently trending due to intense anticipation surrounding its upcoming Cohort 4 data readout for Soquelitinib in atopic dermatitis, expected in January. The community is highly optimistic about the novel oral therapy's potential and its broader implications for autoimmune diseases, with much discussion centering on whether the recent cancellation of a major industry conference presentation hints at a significant partnership or buyout alongside positive results.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma ($FIG) is trending amid significant downward pressure, with community chatter centered on its post-IPO performance, substantial insider selling, and upcoming lock-up expirations, fueling concerns about its valuation. While some view the rapid decline as a "scam IPO" or vulnerability to AI replacing design roles, others see an oversold opportunity, highlighting Figma's strong product adoption, market share dominance, and strategic AI integrations as potential drivers for a rebound.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is experiencing strong bullish sentiment, consistently reaching new all-time highs as the community anticipates robust performance in its upcoming earnings. Investors are actively discussing the positive impact of recently announced share buybacks, significant global defense spending, and promising advancements in Small Modular Reactors and next-generation aero engine projects, all contributing to confidence in the company's strategic direction.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is attracting significant attention following its strategic partnership with World Liberty Finance, alongside upcoming launches of its Super App and anticipated collaborations with Stellar and Ripple. The community is highly optimistic, emphasizing ZBCN's robust ISO 20022 and MiCA compliance, which positions it as a key player in real-world on-chain payroll and a compelling early investment opportunity among utility tokens.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is actively trending amid intense political discourse surrounding recent developments, including the narrative around a perceived Nobel Peace Prize for the former President and his controversial stance on acquiring Greenland with tariff threats. Community discussions are highly polarized, debating recent ICE actions in Minneapolis, alleged financial improprieties related to the company's merger, and ongoing legal battles. The stock remains a focal point for broader political commentary rather than purely financial analysis, reflecting deep divisions.

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings Ltd (SPHL) is trending due to recent international expansion news and a solar partnership in Singapore, which ignited a massive, multi-hundred percent surge. The community is actively debating whether this is a legitimate 'green infra pivot' or another 'pump and dump' driven by its low share float, drawing comparisons to other volatile micro-cap runners.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin (AMRN) is actively discussed as investors await key decisions, notably a Supreme Court ruling on its patent infringement dispute and the outcome of China's National Reimbursement Drug List. These events, alongside recent FDA clarification on fenofibrates opening a market opportunity, drive community debate and speculation around a potential strategic acquisition, with some highlighting observed European market alignments.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant (QNT) is generating significant conversation due to its foundational role in programmable money and multi-chain interoperability, with the community actively discussing its Overledger technology powering live initiatives like the UK's tokenized deposits pilot with major financial institutions. Despite some past price volatility, holders remain confident in QNT's limited supply and strategic positioning to bridge legacy finance with future CBDC systems. Many view current levels as an accumulation opportunity, anticipating substantial growth driven by its enterprise utility and recent infrastructure developments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurobiological Technologies, Inc. engages in the manufacture of biological products. The company was founded by Enoch Callaway and John B. Stuppin on August 27, 1987 and is headquartered in Emeryville, CA.

NTII
Neurobiological Technologies Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest NTII News

NTIINeurobiological Technologies Inc.